OIS@AAO
The FluidVision AIOL is the first “true shape-changing, fluid-driven intraocular lens (IOL),” according to PowerVision, which means it creates a continuously variable monofocal lens and…
Read MoreZepto – Mynosys’ capsulotomy device used in a one-time method – was launched in India, Australia, Germany, and the US in 2017. The US clinical…
Read MoreAvedro uses noninvasive strengthening of the cornea with topical drops and photoactivation without surgery or implants to reshape the cornea through cross-linking. The two major…
Read MoreA five-minute noninvasive transscleral treatment: Aciont’s Visual XP is used to deliver molecules passively. Another treatment, Visual XI, is based on iontopheresis and enables the…
Read MoreEyeGate Pharma is taking two technology platforms quickly through to commercialization, CEO Stephen From said. The first is a hyaluronic acid (HA) the company is…
Read MoreNovaliq’s mission is to “transform ocular therapeutics” using a proprietary water-free platform to accomplish the goal. A key limitation of water-based technologies is bioavailability, which…
Read MoreBio-Tissue is the pioneer of the birth tissue industry, said CTO Scheffer Tseng. Biotissue is cryopreserved, and boasts anti-inflammation, anti-scarring, anti-angiogenesis, and promotion of wound…
Read MoreThis company has developed a cell-based therapy (jCell) to preserve and restore vision in people with retinitis pigmentosa (RP), although the therapy is potentially applicable…
Read MoreNightstar’s mission is to maintain and restore vision in blinding inherited retinal diseases. To that end, the company has seven retinal programs under license. Its…
Read MoreDevoted to developing genetic therapies through the use of vector technologies and dosing for patients with inherited retinal diseases, AGTC has partnered with Biogen and…
Read MoreThe AcuFocus platform differs from other solutions in that others rearrange the blur commonly found with presbyopia and other refractive errors, while the AcuFocus platform…
Read MoreThe current standard of care for glaucoma involves reducing intraocular pressure, whether through medication use or surgery, or some combination of the two. But with…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.